Wed.Mar 27, 2024

article thumbnail

The Food is Medicine movement originators are trying to standardize medically tailored meals

STAT

WASHINGTON — Food corporations, grocery stores, and even tech companies are claiming they are a part of the growing effort to use food to treat medical conditions. Now, the nonprofits that pioneered the work want to standardize it. The Food is Medicine Coalition, an association of community-based nonprofit food providers, released a 32-page accreditation standard, which was shared first with STAT Wednesday.

article thumbnail

Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS

PharmaVoice

Ahead of more guidance from the FDA on diversity in clinical trials, Takeda is aiming to beat industry standards.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: AstraZeneca sues Arkansas over the role of pharmacies in a federal discount drug program

STAT

AstraZeneca filed a lawsuit seeking to block an Arkansas law that requires the company to ship its medicines to any pharmacy working with hospitals participating in a controversial federal discount program. The move comes less than a month after a U.S. appeals court upheld the same law, but the company is trying to make a different argument in hopes of stopping other states from pursuing similar laws.

Hospitals 164
article thumbnail

Reuters Pharma USA 2024 - Day 2

pharmaphorum

Get live coverage of the latest updates and developments from Day 2 of Reuters Pharma USA 2024. Stay informed with real-time news and insights from the event.

95
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Borrowing an idea from cancer immunotherapy, scientists make old-mice immune systems youthful again

STAT

One of the indignities of getting older is the way your body’s defenses against microbes begin to break down, leaving you extra vulnerable to infection. Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “ twilight of immunity. ” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.

Immunity 195
article thumbnail

Veeda Clinical Research acquires Heads, a European CRO

Express Pharma

Veeda Clinical Research has acquired Heads, a privately held European CRO, which specialises in conducting clinical trials in oncology. Established in 2010, Heads has operational presence in 25 multiple strategically important locations across Europe, North America and Asia Pacific region. Veeda expands its reach to major geographies and adds capabilities of late-sta. ge clinical trial execution with strong focus on oncology with this acqusition The acquisition provides Heads a strong operationa

77

More Trending

article thumbnail

PhaSER Biomedical and the Sanders TDI partner for clinical drug discovery research

Pharma Times

PhaSER will provide 8HUM mouse models for the TDI to accelerate a pipeline of novel therapeutic targets

103
103
article thumbnail

Brazil’s plan for low-cost CAR-Ts

STAT

New biotech newsletter launching tomorrow. Don’t miss out. Good morning, everyone. Damian here with the details on a potentially major drug approval, an idea to make CAR-T more equitable, and the slow launch of a gene therapy.

article thumbnail

Building the patient experience into observational studies produces stronger real-world evidence

pharmaphorum

Incorporating the patient experience into observational studies can enhance the quality of real-world evidence gathered. Learn how patient-centred approaches can lead to stronger research outcomes.

65
article thumbnail

STAT+: Pharmalittle: We’re reading about abortion pill arguments, a Merck drug approval, and more

STAT

Hello, everyone, and welcome to the middle of the week. Congratulations on making it this far, because it is an accomplishment, after all. The next step, of course, is to forge ahead. And why not? Just consider the alternatives. On that optimistic note, please join us for a needed cup or three of stimulation. Our choice today is caramel crème brulée.

150
150
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Brainomix AI shows its worth in AZ pulmonary fibrosis trial

pharmaphorum

Brainomix's e-Lung AI can accurately identify idiopathic pulmonary fibrosis patients most likely to progress and could inform the clinical trial design for new therapies

74
article thumbnail

Gut bacteria could play role in kidney autoimmune disease, study shows

STAT

Right now, inside your digestive tract, there are trillions of bacteria, fungi, and viruses that form a tiny universe known as the gut microbiome. New research shows that certain bacteria can alter antibodies so much that they’re unrecognizable to the body’s defenses — potentially leading to immune friendly fire. The bacteria, called Akkermansia muciniphila, can strip the sugar coating from IgA antibodies, immune proteins abundant in the gut.

Immunity 148
article thumbnail

Japan clears first CLDN18.2 drug, Astellas’ Vyloy

pharmaphorum

Astellas has become the first drugmaker to bring a claudin 18.2 (CLDN18.2) targeted therapy to regulatory approval, getting a green light in Japan for Vyloy as a treatment for stomach cancer. The Ministry of Health, Labour and Welfare (MHLW) has cleared Vyloy (zolbetuximab) for use in combination with chemotherapy for patients with HER2-negative CLDN18.2-positive advanced or recurrent gastric cancer that cannot be treated with surgery.

article thumbnail

Leveraging Digital Tools to Optimize Manufacturing Processes

Pharmaceutical Commerce

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses how companies can leverage digital tools like artificial intelligence and machine learning to optimize manufacturing processes and ensure efficient production.

76
article thumbnail

European study finds popular ALS drug ineffective

BioPharma Dive

The failure of a medicine known as TUDCA is yet another disappointment for ALS patients, as it comes just after Amylyx’s therapy Relyvrio proved unsuccessful in confirmatory testing.

75
article thumbnail

Women in Science: Follow your passion and you’ll get to where you’re meant to be - Jennifer Visser-Rogers

Outsourcing Pharma

From math hater to a leader in clinical data, itâs been a long journey for Jennifer Visser-Rogers, vice president for statistical research and consultancy at Phastar.

70
article thumbnail

No 'blurred lines' between pharmacy professionals, officials tell inquiry

The Pharmacist

Government and NHS officials have refuted a suggestion that the lines between pharmacists and pharmacy technicians are being 'blurred'. Speaking at the Health and Social Care (HSCC)’s pharmacy inquiry this week, Birmingham (Erdington) MP Paulette Hamilton said she was ‘concerned’ about the way pharmacy technicians were being represented to the public, and claimed some were […] The post No 'blurred lines' between pharmacy professionals, officials tell inquiry appeared first on The

article thumbnail

Dissatisfaction with NHS ‘at record high’

pharmaphorum

More than half (52%) of people who participated in a major survey of the GB public were dissatisfied with the NHS, as staff shortages, strikes, and record waiting lists take their toll. The results from the annual British Social Attitudes (BSA) survey came from 3,000 people interviewed across England, Scotland, and Wales and showed that less than a quarter (24%) were satisfied with the health service, a 29 percentage drop in three years.

64
article thumbnail

First-in-class biologic approved for rare lung disease

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved WINREVAIR ( sotatercept -csrk) for subcutaneous injection (45mg, 60mg) for adults with pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1). According to Merck (MSD outside of the US and Canada), WINREVAIR is the first activin signalling inhibitor therapy authorised for PAH.

article thumbnail

Prioritizing women, promoting diversity and a patient-first approach - how does CTM do it?

Outsourcing Pharma

OSP senior editor, Liza Laws, took some time at SCOPE 2024 in Orlando earlier in the year to speak with two female-focused members of the Clinical Trials Media (CTM) team, Katherine Seay and Veronica Berk to find out how.

59
article thumbnail

Heidelberg Pharma gains FDA ODD for ATAC candidate

Pharmafile

Heidelberg Pharma has announced that it has gained Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for HDP-101 for the treatment of multiple myeloma. The candidate is currently being investigated in a phase 1/2a clinical trial for the treatment of relapsed and refractory multiple myeloma (RRMM). HDP-101 is an antibody-drug conjugate […] The post Heidelberg Pharma gains FDA ODD for ATAC candidate appeared first on Pharmafile.

59
article thumbnail

Cipla enters deal to distribute Sanofi’s CNS products in India

Pharmaceutical Business Review

This collaboration is expected to leverage Cipla’s extensive distribution network to enhance the reach of Sanofi India’s CNS products. Under the agreement, Cipla will handle the distribution and promotion of six CNS brands owned by Sanofi India, including the anti-epileptic medication Frisium. Sanofi India retains ownership and will continue to import and manufacture products under its CNS range across plants in India and globally.

article thumbnail

FDA approves Merck’s Winrevair for PAH treatment

Pharmafile

Merck, known as MSD outside of the US and Canada, has announced that the US Food and Drug Administration (FDA) has approved Winrevair (sotatercept-csrk) for the treatment of adult patients with pulmonary arterial hypertension (PAH). The drug is intended to increase exercise capacity, improve World Health Organization (WHO) functional class (FC) and reduce risk of […] The post FDA approves Merck’s Winrevair for PAH treatment appeared first on Pharmafile.

59
article thumbnail

Teva UK partners Closed Loop on personalised medicine

pharmaphorum

Teva UK has joined forces with techbio company Closed Loop Medicine to develop digital companions for pharma products that could provide personalised medicine

59
article thumbnail

Boundless Bio breaks IPO lull with $100M fundraise

BioPharma Dive

The startup’s performance will test investors’ appetite for early-stage drugmakers, as Boundless has only advanced as far as Phase 1 clinical trials.

60
article thumbnail

LifeArc provides £750,000 fund for clinical trial to treat neuroferritinopathy

Pharma Times

The progressive and incurable brain disorder currently affects approximately 100 patients worldwide

71
article thumbnail

Omega-3s and Stress Reduction: WellPure 1300 EC Boosts Calm

Welltopia Pharmacy

Omega-3s and Stress Reduction: Unveiling the Calming Power of WellPure Omega 1300 EC Omega-3s and Stress Reduction In the whirlwind

64
article thumbnail

Drug safety driving pyrogen testing market expansion

European Pharmaceutical Review

A report by Allied Market Research has predicted that the global pyrogen testing market will value $3.3 billion by 2032. The market is predicted to grow at a CAGR of 8.2 percent from 2023 to 2032, according to the research. Drivers of the pyrogen testing market Increased R&D activities within the pharmaceutical and biopharmaceutical sector and a focus on biologics, were reported to hold significant growth opportunities for the pyrogen testing market.

53
article thumbnail

New patent for Haleon Us drug ADVIL DUAL ACTION WITH ACETAMINOPHEN

Drug Patent Watch

Annual Drug Patent Expirations for ADVIL+DUAL+ACTION+WITH+ACETAMINOPHEN Advil Dual Action With Acetaminophen is a drug marketed by Haleon Us Holdings and is included in one NDA.

52
article thumbnail

Strong growth for Sweden’s pharmaceutical exports

European Pharmaceutical Review

According to SwedenBIO, Sweden‘s life sciences industry is witnessing a continued increase in export values. Based on statistics from Statistics Sweden, at SEK 152.5 billion, exports of pharmaceuticals reached a total of 7.3 percent of Sweden’s total export value. SwedenBIO highlighted that this is an almost 10 percent increase since 2022. Value of Swedish pharmaceutical exports Swedish pharmaceuticals exports are currently “significantly larger” than exports of iron and steel.

article thumbnail

Challenges in Trial Access and Treatment for Women with Chronic Illnesses

PharmExec

In this Pharmaceutical Executive video interview, Marie Teil, Global Head of UCB’s Women of Childbearing Age Program, discusses the specific challenges women with chronic illnesses face when it comes to accessing and participating in clinical research.

52
article thumbnail

How cell and gene therapies are infusing blood centres with new purpose

pharmaphorum

Explore how cell and gene therapies are revolutionising blood centres and giving them new purpose. Learn about the innovative ways in which these therapies are being infused into the field.

52
article thumbnail

Oncology in 2024: The clinical trial trends reshaping the role of CROs

Pharmaceutical Technology

CROs are fundamental to the development of cancer treatments but face multiple challenges. We analyze the biggest trends in oncology and the technological solutions available to CROs to optimize efficiencies.

52
article thumbnail

Pharmacotherapy For Bone Pain In Cancer Patients

Med Ed 101

For cancer patients, bone pain can be one of the most distressing symptoms to manage. Whether it’s due to metastasis, chemotherapy-induced effects, or other factors, finding effective pain relief is crucial for improving quality of life. In the realm of pain management, there exists a drug of choice along with various alternatives, each with its […] The post Pharmacotherapy For Bone Pain In Cancer Patients appeared first on Med Ed 101.

article thumbnail

Which drugs are most likely to be approved in Cryopyrin-Associated Periodic Syndromes?

Pharmaceutical Technology

Cryopyrin-Associated Periodic Syndromes disease is an indication for drug development with over 10 pipeline drugs currently active according to GlobalData.